253 related articles for article (PubMed ID: 30925905)
1. Weighted correlation network and differential expression analyses identify candidate genes associated with BRAF gene in melanoma.
Zhao B; You Y; Wan Z; Ma Y; Huo Y; Liu H; Zhou Y; Quan W; Chen W; Zhang X; Li F; Zhao Y
BMC Med Genet; 2019 Mar; 20(1):54. PubMed ID: 30925905
[TBL] [Abstract][Full Text] [Related]
2. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.
Wang LX; Li Y; Chen GZ
PLoS One; 2018; 13(1):e0190447. PubMed ID: 29377892
[TBL] [Abstract][Full Text] [Related]
3. Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
Chen S; Liu Z; Li M; Huang Y; Wang M; Zeng W; Wei W; Zhang C; Gong Y; Guo L
Curr Gene Ther; 2020; 20(1):5-14. PubMed ID: 32416689
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of a BRAF mutation-associated gene expression signature in melanoma.
Johansson P; Pavey S; Hayward N
Pigment Cell Res; 2007 Jun; 20(3):216-21. PubMed ID: 17516929
[TBL] [Abstract][Full Text] [Related]
5. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
Wang HZ; Wang F; Chen PF; Zhang M; Yu MX; Wang HL; Zhao Q; Liu J
Biomed Pharmacother; 2019 Mar; 111():1234-1242. PubMed ID: 30841437
[TBL] [Abstract][Full Text] [Related]
6. RTP4 is a novel prognosis-related hub gene in cutaneous melanoma.
Li Y; Qi J; Yang J
Hereditas; 2021 Jun; 158(1):22. PubMed ID: 34154655
[TBL] [Abstract][Full Text] [Related]
7. Common Nevus and Skin Cutaneous Melanoma: Prognostic Genes Identified by Gene Co-Expression Network Analysis.
Yang L; Xu Y; Yan Y; Luo P; Chen S; Zheng B; Yan W; Chen Y; Wang C
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557882
[TBL] [Abstract][Full Text] [Related]
8. Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
Loria R; Bon G; Perotti V; Gallo E; Bersani I; Baldassari P; Porru M; Leonetti C; Di Carlo S; Visca P; Brizzi MF; Anichini A; Mortarini R; Falcioni R
Oncotarget; 2015 Feb; 6(5):2779-93. PubMed ID: 25576923
[TBL] [Abstract][Full Text] [Related]
9. High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
van den Hurk K; Balint B; Toomey S; O'Leary PC; Unwin L; Sheahan K; McDermott EW; Murphy I; van den Oord JJ; Rafferty M; FitzGerald DM; Moran J; Cummins R; MacEneaney O; Kay EW; O'Brien CP; Finn SP; Heffron CC; Murphy M; Yela R; Power DG; Regan PJ; McDermott CM; O'Keeffe A; Orosz Z; Donnellan PP; Crown JP; Hennessy BT; Gallagher WM
Melanoma Res; 2015 Jun; 25(3):189-99. PubMed ID: 25746038
[TBL] [Abstract][Full Text] [Related]
10. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
Lázár V
Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
[TBL] [Abstract][Full Text] [Related]
11. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Guo X; Xu Y; Zhao Z
Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
[TBL] [Abstract][Full Text] [Related]
12. AKT1 as the PageRank hub gene is associated with melanoma and its functional annotation is highly related to the estrogen signaling pathway that may regulate the growth of melanoma.
Zhao J; Zeng X; Song P; Wu X; Shi H
Oncol Rep; 2016 Oct; 36(4):2087-93. PubMed ID: 27573172
[TBL] [Abstract][Full Text] [Related]
13. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
[TBL] [Abstract][Full Text] [Related]
14. Co-expression modules construction by WGCNA and identify potential prognostic markers of uveal melanoma.
Wan Q; Tang J; Han Y; Wang D
Exp Eye Res; 2018 Jan; 166():13-20. PubMed ID: 29031853
[TBL] [Abstract][Full Text] [Related]
15. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
17. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.
Dadzie OE; Yang S; Emley A; Keady M; Bhawan J; Mahalingam M
Br J Dermatol; 2009 Feb; 160(2):368-75. PubMed ID: 18945298
[TBL] [Abstract][Full Text] [Related]
18. The plasma membrane Ca
Hegedũs L; Garay T; Molnár E; Varga K; Bilecz Á; Török S; Padányi R; Pászty K; Wolf M; Grusch M; Kállay E; Döme B; Berger W; Hegedũs B; Enyedi A
Int J Cancer; 2017 Jun; 140(12):2758-2770. PubMed ID: 27813079
[TBL] [Abstract][Full Text] [Related]
19. Expression of AID in malignant melanoma with BRAF(V600E) mutation.
Okura R; Yoshioka H; Yoshioka M; Hiromasa K; Nishio D; Nakamura M
Exp Dermatol; 2014 May; 23(5):347-8. PubMed ID: 24684646
[TBL] [Abstract][Full Text] [Related]
20. A multigene support vector machine predictor for metastasis of cutaneous melanoma.
Wei D
Mol Med Rep; 2018 Feb; 17(2):2907-2914. PubMed ID: 29257259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
